EoPancreas: New Diabetes Patch Pump and CGM System in Development

FDA has granted "Breakthrough Device Designation" to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
FDA has granted Breakthrough Device Designation to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.

Quarterly Update Diabetes Technology

Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus - ScienceDirect

3 Updates on Diabetes Technology You Don't Want to Miss

Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Artificial Pancreas aka Automated Insulin Delivery: What You Should

Medtronic nixes $738M deal for insulin patch pump maker EOFlow

Artificial Pancreas Improves Glycemic Control in Young Kids With T1D

Diabetes Management with Insulin Pumps and CGMs (Continuous Glucose Monitors)

Experts Offer Insights Into Hassles, Benefits of Diabetes Technology

A Guide to Insulin Pumps and New Diabetes Technology

Insulin Pump Therapy - Southside Diabetes

Insulin Pump Belt, No-Bounce Insulin Pump Holder Compatible with Tandem t:Slim/t:Slim X2, Medical Expandable Waist Pouch, Adjustable Diabetic Band Accessories, Diabetic Supplies : Health & Household

Omnipod DASH Tubeless Insulin Pump: Hands-on Review

Study: 'Bionic pancreas' improves type 1 diabetes control - UW Medicine